Yüklüyor......
Is polypharmacy beneficial or detrimental for older adults with cardiometabolic multimorbidity? Pooled analysis of studies from Hong Kong and Europe
BACKGROUND: Physicians often prescribe high numbers of medications for managing multiple cardiometabolic diseases. It is questionable whether polypharmacy (concurrent use of five or more medications) is beneficial or detrimental for older adults with cardiometabolic multimorbidity (co-occurrence of...
Kaydedildi:
| Yayımlandı: | Fam Pract |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7699312/ https://ncbi.nlm.nih.gov/pubmed/32596732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/fampra/cmaa062 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|